Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and
申请人:Eli Lilly and Company
公开号:US05637624A1
公开(公告)日:1997-06-10
The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes which exhibit binding activity at the serotonin 1A receptor.
The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes, including their corresponding sulfoxides and sulfones, which ring-substituted compounds exhibit agonist activity at the serotonin 1A receptor.
The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes, including their corresponding sulfoxides and sulfones, which ring-substituted compounds exhibit agonist activity at the serotonin 1A receptor.
Method of inhibiting gastric acid secretion with n-arylpiperazines
申请人:Eli Lilly and Company
公开号:US05258379A1
公开(公告)日:1993-11-02
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and
申请人:Eli Lilly and Company
公开号:US05286753A1
公开(公告)日:1994-02-15
The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes, including their corresponding sulfoxides and sulfones, which ring-substituted compounds exhibit agonist activity at the serotonin 1A receptor.